Cargando…
Automated high-throughput image processing as part of the screening platform for personalized oncology
Cancer is a devastating disease and the second leading cause of death worldwide. However, the development of resistance to current therapies is making cancer treatment more difficult. Combining the multi-omics data of individual tumors with information on their in-vitro Drug Sensitivity and Resistan...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060403/ https://www.ncbi.nlm.nih.gov/pubmed/36991084 http://dx.doi.org/10.1038/s41598-023-32144-z |
_version_ | 1785017089436680192 |
---|---|
author | Schilling, Marcel P. El Khaled El Faraj, Razan Urrutia Gómez, Joaquín Eduardo Sonnentag, Steffen J. Wang, Fei Nestler, Britta Orian-Rousseau, Véronique Popova, Anna A. Levkin, Pavel A. Reischl, Markus |
author_facet | Schilling, Marcel P. El Khaled El Faraj, Razan Urrutia Gómez, Joaquín Eduardo Sonnentag, Steffen J. Wang, Fei Nestler, Britta Orian-Rousseau, Véronique Popova, Anna A. Levkin, Pavel A. Reischl, Markus |
author_sort | Schilling, Marcel P. |
collection | PubMed |
description | Cancer is a devastating disease and the second leading cause of death worldwide. However, the development of resistance to current therapies is making cancer treatment more difficult. Combining the multi-omics data of individual tumors with information on their in-vitro Drug Sensitivity and Resistance Test (DSRT) can help to determine the appropriate therapy for each patient. Miniaturized high-throughput technologies, such as the droplet microarray, enable personalized oncology. We are developing a platform that incorporates DSRT profiling workflows from minute amounts of cellular material and reagents. Experimental results often rely on image-based readout techniques, where images are often constructed in grid-like structures with heterogeneous image processing targets. However, manual image analysis is time-consuming, not reproducible, and impossible for high-throughput experiments due to the amount of data generated. Therefore, automated image processing solutions are an essential component of a screening platform for personalized oncology. We present our comprehensive concept that considers assisted image annotation, algorithms for image processing of grid-like high-throughput experiments, and enhanced learning processes. In addition, the concept includes the deployment of processing pipelines. Details of the computation and implementation are presented. In particular, we outline solutions for linking automated image processing for personalized oncology with high-performance computing. Finally, we demonstrate the advantages of our proposal, using image data from heterogeneous practical experiments and challenges. |
format | Online Article Text |
id | pubmed-10060403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100604032023-03-31 Automated high-throughput image processing as part of the screening platform for personalized oncology Schilling, Marcel P. El Khaled El Faraj, Razan Urrutia Gómez, Joaquín Eduardo Sonnentag, Steffen J. Wang, Fei Nestler, Britta Orian-Rousseau, Véronique Popova, Anna A. Levkin, Pavel A. Reischl, Markus Sci Rep Article Cancer is a devastating disease and the second leading cause of death worldwide. However, the development of resistance to current therapies is making cancer treatment more difficult. Combining the multi-omics data of individual tumors with information on their in-vitro Drug Sensitivity and Resistance Test (DSRT) can help to determine the appropriate therapy for each patient. Miniaturized high-throughput technologies, such as the droplet microarray, enable personalized oncology. We are developing a platform that incorporates DSRT profiling workflows from minute amounts of cellular material and reagents. Experimental results often rely on image-based readout techniques, where images are often constructed in grid-like structures with heterogeneous image processing targets. However, manual image analysis is time-consuming, not reproducible, and impossible for high-throughput experiments due to the amount of data generated. Therefore, automated image processing solutions are an essential component of a screening platform for personalized oncology. We present our comprehensive concept that considers assisted image annotation, algorithms for image processing of grid-like high-throughput experiments, and enhanced learning processes. In addition, the concept includes the deployment of processing pipelines. Details of the computation and implementation are presented. In particular, we outline solutions for linking automated image processing for personalized oncology with high-performance computing. Finally, we demonstrate the advantages of our proposal, using image data from heterogeneous practical experiments and challenges. Nature Publishing Group UK 2023-03-29 /pmc/articles/PMC10060403/ /pubmed/36991084 http://dx.doi.org/10.1038/s41598-023-32144-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Schilling, Marcel P. El Khaled El Faraj, Razan Urrutia Gómez, Joaquín Eduardo Sonnentag, Steffen J. Wang, Fei Nestler, Britta Orian-Rousseau, Véronique Popova, Anna A. Levkin, Pavel A. Reischl, Markus Automated high-throughput image processing as part of the screening platform for personalized oncology |
title | Automated high-throughput image processing as part of the screening platform for personalized oncology |
title_full | Automated high-throughput image processing as part of the screening platform for personalized oncology |
title_fullStr | Automated high-throughput image processing as part of the screening platform for personalized oncology |
title_full_unstemmed | Automated high-throughput image processing as part of the screening platform for personalized oncology |
title_short | Automated high-throughput image processing as part of the screening platform for personalized oncology |
title_sort | automated high-throughput image processing as part of the screening platform for personalized oncology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060403/ https://www.ncbi.nlm.nih.gov/pubmed/36991084 http://dx.doi.org/10.1038/s41598-023-32144-z |
work_keys_str_mv | AT schillingmarcelp automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT elkhaledelfarajrazan automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT urrutiagomezjoaquineduardo automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT sonnentagsteffenj automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT wangfei automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT nestlerbritta automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT orianrousseauveronique automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT popovaannaa automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT levkinpavela automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology AT reischlmarkus automatedhighthroughputimageprocessingaspartofthescreeningplatformforpersonalizedoncology |